AMR Centre candidate targets superbugs with problem metallo-β-lactamase enzymes

The AMR Centre has nominated a preclinical candidate in its program that tackles drug resistance conferred by NDM-1 and other…

The AMR Centre set for partnership with Shionogi for new superbug therapy

The AMR Centre Ltd has today announced a landmark agreement with the Japanese pharma company Shionogi to take forward its anti-virulence…

AMR Centre to join first life sciences delegation to Biomed in Israel

The North’s life sciences landscape will be showcased on an international stage at a leading Israeli medtech conference.

The AMR Centre secures £2.3m funding boost

The AMR Centre has received a significant funding package to support the expansion of its pipeline of new drugs to treat drug-resistant…

Partnering for 2019

The AMR Centre is searching for new collaborative opportunities throughout 2019.

AMR Centre marks UN International Day of Women and Girls in Science

Today marks the official UN International Day of Women and Girls in Science.

AMR Centre hails government action plan as ‘critical step’ in tackling antibiotic crisis

Today’s announcement by the UK Government on the launch of a trial to evaluate a new way for the National Health Service (NHS) to pay for…

International Trade Minister visits AMR Centre

The AMR Centre was delighted to welcome Baroness Rona Fairhead to Alderley Park, where scientists play a key role in combating the global…

Fighting back against AMR

During BioInfect 2018, Dr Peter Jackson took part in a podcast with Dr Werner Lanthaler, CEO of Evotec. You can hear their thoughts here.

Industry group calls for action over £500m funding gap on AMR

A life science industry report representing 36 key businesses and organisations concerned about the growing impact of anti-microbial…